Coverage for high-cost, specialty drugs missing from rollout of feds’ pharmacare plan: experts
While the concept behind the federal government’s universal pharmacare plan is well intentioned, the program would make a larger impact for employers by focusing on high-cost and specialty drugs, says Pam Martin, vice-president and senior consultant at Baynes & White Inc. In theory, the way that the government is rolling out the program in small […]
- May 29, 2024 May 28, 2024
- 09:00